Sudha S Murthy

Medical doctor , oncopathologist, MSc , Precision cancer medicine ( University of Oxford) , Healthcare management ( ISB)

[Sudha S Murthy @sudhamurthy1]

@Sinchita_Roy @UTMDAnderson @lungoncdoc @DrMCabanillas @DrAManiakas @MehmetAltanMD This is very useful Kudos @Sinchita_Roy and team Thaks for sharing

[Sudha S Murthy @sudhamurthy1]

HER2 in Gynae Cancers (2026): From biomarker to therapeutic gateway. 🔓
The landscape is shifting toward ADCs and HER2-low targeting. Refer to NCCN, ESMO, ESTRO guidelines
My perspective below
#GynaeCancer #Oncology #Pathology #Biomarker #PrecisionCancerMedicine #MedEd

[Sudha S Murthy @sudhamurthy1]

@isliquidbiopsy @UmbertoMalapel1 @ChristianRolfo Hearty congratulations @UmbertoMalapel1 Kudos to your efforts on creating awareness on liquid biopsy

[Sudha S Murthy @sudhamurthy1]

@aaditsh AI

[Sudha S Murthy @sudhamurthy1]

@ACTREC_TMC @nvpatkar @JCO_ASCO Hearty congratulations to the team ! Once again provides evidence that biology-driven precision can redefine standard therapy💐💐

[Sudha S Murthy @sudhamurthy1]

@Sinchita_Roy @cytopathology @CancerCytopath Hearty congratulations @Sinchita_Roy

[Sudha S Murthy @sudhamurthy1]

#Liquidbiopsy on the road: truth or illusion?

A 65-year-old with colon cancer gets a blood test 200 km away. The ctDNA report comes back negative
Watch the full video here 👉 https://t.co/KLmch2z0PU
Please like , subscribe and share

[Sudha S Murthy @sudhamurthy1]

@VijayPatho Dear Sir/ Madam

Inviting you to a scheduled Zoom meeting.

Topic: Condolence Meeting for Dr. Anita Borges
Time: Sep 23, 2025 03:00 PM India

Join Zoom from PC, Mac, iOS or Android:
https://t.co/3WDJUARBD8

Meeting ID: 828 0355 9404
Password: 526063

[Vijay Shankar S @VijayPatho]

We are deeply saddened by the passing of Dr. Anita Borges, a doyen of pathology in India and an eminent pathologist of national and international repute.

Her remarkable contributions, dedication, and zeal have left an indelible mark on the field of pathology, inspiring generations of pathologists and medical professionals.
we lost a stalwart and a great teacher. She was involved in teaching even in the last moments of her life!
Words cannot describe her aura she carried.
Her loss creates an irreplaceable void in our fraternity.

May her noble soul rest in eternal peace, and may her legacy continue to guide and inspire us.
@BinXu16 @smlungpathguy @JMGardnerMD
@DrGeeONE @pembeoltulu @adi_agnihotri
@SaranyaS @archibhat3 @vi_monappa @erikanuradha @kriyer68 @DrAhmedKalebi
@PanditApoorva @RamyaPathology
@DrNithyashree @DrVasudevPrabhu
@GIJamesMD @HermelinMD @faheema_hasan
@TristanRutland7 @KMirza @pathridle_susan
@DraEosina @cebulka26 @Baskotacytopath
@Path_Matt @ariella8 @sranna86 @Thejaspatho
@tumashankar @raghupillappa

[ASCO HealthPolicyCoP @healthpolicycop]

We are proud to welcome and congratulate our new CoP Subcommittee leaders across Social Media, Research, Community/Rural, Global, AI and more. Your leadership will shape how we connect, advocate, and grow together. @ASCO #ASCO_CoP #policy #advocacy

[Sudha S Murthy @sudhamurthy1]

@isliquidbiopsy Great going Thank you @isliquidbiopsy @UmbertoMalapel1

[International Society of Liquid Biopsy @isliquidbiopsy]

📢 Big News from ISLB!
The Journal of Liquid Biopsy is Now Indexed in Scopus 🎉

We’re proud to share that the Journal of Liquid Biopsy — the official journal of the International Society of Liquid Biopsy (ISLB) — has been accepted for indexing on the Scopus platform!

This major milestone highlights the growing impact and credibility of research in liquid biopsy. On behalf of our Editor-in-Chief @UmbertoMalapel1 , @ElsevierConnect , and the editorial board, we extend our deepest thanks to all our authors, reviewers, and readers for making this possible.

🗓️ Articles will be listed on the Scopus Title list by late July/early August, and first citations are expected within 2–3 months.

📚 About the Journal:
@jlb_islb publishes cutting-edge research focused on liquid biopsy-based biomarkers (cfDNA, ctDNA, miRNA, CTCs, EVs, proteins, and more), encouraging an integrated approach across molecular science, technical innovation, and clinical application.

🔗 Learn more: https://t.co/QJTSvdlwjp

#ISLB #LiquidBiopsy #Scopus #OpenAccess #PrecisionOncology #MolecularDiagnostics

@ChristianRolfo @ElJanLe @RobertoBoreaMD
@DrYukselUrun @ErulEnes @UmbertoMalapel1 @drgandara @MJOSESERRANO19 @ReduzziCarol

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

Every cancer patient deserves a diagnosis

Providing links. as requested.

2016 AMA journal paper:
https://t.co/BkEq2r1YRu

2023 ASCO journal paper
https://t.co/vejItiKryV

@VivekSubbiah

[Sudha S Murthy @sudhamurthy1]

@DrYukselUrun @UmbertoMalapel1 @PTarantinoMD @yekeduz_emre @PGrivasMDPhD @matteolambe @neerajaiims @AurelianoStingi @SuyogCancer @DrNikitaMehra @JackWestMD Amazing Real world data HER2 3+ rates >10% in bladder, uterine serous, GEJ tumors Significant findings of no HER2 expression In many tumors - Not to lose focus ; Need not test in all tumours Thank you @DrYukselUrun @UmbertoMalapel1

[Yüksel Ürün @DrYukselUrun]

Real-world HER2 testing across 65,000+ solid tumors after T-DXd approval.
🧬Highest HER2 3+ rates:
Bladder 13.9%
Uterine serous 13.6%
GEJ 12.1%
Breast 7.8%
Gastric 6.6%
🧬0% in glioma, sarcoma, SCLC, GIST, thyroid, thymic...
Routine HER2 IHC may not be needed for all tumors.
@JAMAOnc @OncoAlert @OncBrothers @US_FDA @myESMO @ASCO
https://t.co/u4vl2NKLnS

[Hidehito HORINOUCHI @HHorinouchi]

🔥@trendscancer🆙
✅Turning cold into hot: emerging strategies to fire up the tumor microenvironment
🎯Summary of the intrinsic, extrinsic, and systemic factors developing ‘cold’ tumors
👥Dr. Kaili Ma
#LCSM @OncoAlert #ICI
https://t.co/p3IW9hjSOi

[Sudha S Murthy @sudhamurthy1]

@Aiims1742 @mason_lab @ElementoLab @WCMEnglanderIPM This is amazing, Sir @Aiims1742 @sudhamurthy1 Thanks for sharing
#spatialatlas #precisioncancermedicine #pathology #anatomy

[Anirban Maitra @Aiims1742]

Absolutely insane amount of data in this resource from @mason_lab
The Spatial Atlas of Human Anatomy (SAHA): A Multimodal Subcellular-Resolution Reference Across Human Organs
https://t.co/rwKWVtidfZ
Spatial data on 15million cells from 100 donors across multiple ages, mainly GI

[Vivek Subbiah, MD @VivekSubbiah]

🚨 Wow! Sunday morning brings an incredible trifecta - 2 @NEJM papers + 1 @TheLancetHaem study dropping simultaneously with #EHA2025! 🩸📚 ⚡️ @OncoAlert
1/3 Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia @NEJM https://t.co/fh7f2NOgdH

[International Society of Liquid Biopsy @isliquidbiopsy]

Great paper from our ISLB Young Committee!
A huge effort to keep sharing #LiquidBiopsy knowledge through reviews and editorials after major conferences worldwide.

Follow us for more LB updates and insights! 🌍🧬
#ISLB #sciencecommunication